Covidien, Aircraft Medical ink deal

Scotland's Aircraft Medical has signed an exclusive agreement through which Covidien ($COV) will market and distribute the former's proprietary McGRATH MAC video laryngoscope in the U.S., U.K., Japan, Latin America, Australia and New Zealand. The agreement will increase the number of specialized sales and marketing personnel promoting the laryngoscope products to more than 500 worldwide.

The low-cost McGRATH MAC combines video and direct visualization to support everything from routine to more difficult intubations and reduces the use of multiple devices. It's also designed to avoid complicating more simple intubations, according to the company's website.

An estimated 17 million intubations using a laryngoscope are done annually in the U.S. The majority of these are performed with Covidien Mallinckrodt endotracheal tubes, thus bringing synergies with the everyday-use McGRATH MAC video laryngoscope.

"Our partnership with Aircraft Medical demonstrates our commitment to deliver clinical value and improve patient outcomes in fast-growing critical-care markets throughout the world," James Willett, VP and general manager, Respiratory and Monitoring Solutions, at Covidien, said in a statement. "By integrating the McGRATH MAC video laryngoscope into our respiratory product portfolio, Covidien can provide critical-care practitioners with a complete intubation solution to meet the needs of the continuum of patients."

- see the Aircraft Medical release

Suggested Articles

Sherlock Biosciences teamed up with Cepheid to help develop its CRISPR-based molecular diagnostic tech in oncology, infections and the coronavirus.

The spine surgery company ATEC has moved to acquire Paris-based EOS imaging, makers of FDA-cleared scanners and 3D orthopedic planning software.

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.